American Journal of Cancer Research,
Год журнала:
2024,
Номер
14(5), С. 2523 - 2537
Опубликована: Янв. 1, 2024
Chemotherapy
is
the
principal
treatment
for
advanced
cancer
patients.However,
chemotherapeutic
resistance,
an
important
hallmark
of
cancer,
considered
as
a
key
impediment
to
effective
therapy
in
patients.Multiple
signaling
pathways
and
factors
have
been
underscored
participate
governing
drug
resistance.Posttranslational
modifications,
including
ubiquitination,
glycosylation,
acetylation
phosphorylation,
emerged
players
modulating
resistance
gynecological
tumors,
such
ovarian
cervical
endometrial
cancer.In
this
review
article,
we
summarize
role
ubiquitination
sensitivity
cancers.Moreover,
describe
numerous
compounds
that
target
cancers
reverse
resistance.In
addition,
provide
future
perspectives
fully
elucidate
mechanisms
by
which
controls
contributing
restoring
sensitivity.This
highlights
complex
interplay
between
providing
novel
insights
into
potential
therapeutic
targets
personalized
strategies
overcome
bottleneck
resistance.
Abstract
Background
Cuproptosis
induces
proteotoxic
stress
and
eventually
leads
to
cell
death.
However,
the
relationship
between
cuproptosis
lncRNAs
in
cervical
cancer
has
not
been
fully
elucidated.
Therefore,
we
aim
explore
association
among
lncRNAs,
clinical
features
cancer.
Methods
RNA
sequencing,
genetic
mutations,
data
of
CESC
patients
were
obtained
from
TCGA.
Cuproptosis-associated
genes
gathered.
WGCNA
was
used
cluster
important
modules,
KEGG,
GO,
GSEA
GSVA
functional
pathway
enrichment.
The
immune
microenvironment
cuproptosis-related
performed
by
using
cibersort
algorithm
other
platforms,
including
XCELL,
TIMER,
QUANTISEQ,
MCPCOUNTER
EPIC.
Fluorescence
quantitative
PCR
employed
detect
expression
LINC01833
LINC02321,
CCK-8
scratch
assays
assess
proliferation
migration
capabilities
after
LINCRNA
interference.
Results
202
upregulated
45
downregulated
selected.
survival
analysis
showed
that
there
a
statistically
significant
difference
rates
high-risk
low-risk
groups.
prognosis
tumour
mutation
burden
degree
infiltration
differed
noticeably
BHG712,
TL-2-105,
FR-180204,
Masitinib,
TAK-715,
ODI-027,
JW-7-24-2,
OSI-930
had
substantially
higher
IC50
values
group.
Notably,
found
AL360178.1
associated
with
RNF44
E3
ubiquitin
ligase
expression.
In
lines,
LINC02321
displayed
upregulation.
Efficient
siRNA
transfection
led
decreased
LINC02321.
This
knockdown
significantly
hindered
both
cells
compared
negative
control.
Conclusion
conclusion,
constructed
five
cuprotosis-related
lncRNA
prognostic
models,
which
may
be
new
tumor
therapeutic
targets
for
prevention
treatment
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Сен. 11, 2024
Osteosarcoma
is
a
common
type
of
bone
cancer
characterized
by
poor
prognosis
due
to
its
metastatic
nature.
The
tumor
microenvironment
(TME)
plays
critical
role
in
metastasis
and
therapy
response.
Therefore,
our
study
aims
explore
the
mechanism
osteosarcoma,
potentially
opening
new
avenues
for
treatment.
Frontiers in Immunology,
Год журнала:
2023,
Номер
14
Опубликована: Май 5, 2023
Bladder
cancer
is
one
of
the
common
malignant
urothelial
tumors.
Post-translational
modification
(PTMs),
including
ubiquitination,
acetylation,
methylation,
and
phosphorylation,
have
been
revealed
to
participate
in
bladder
initiation
progression.
Ubiquitination
PTM,
which
conducted
by
E1
ubiquitin-activating
enzyme,
E2
ubiquitin-conjugating
enzyme
E3
ubiquitin-protein
ligase.
ubiquitin
ligases
play
a
key
role
oncogenesis
progression
drug
resistance
cancer.
Therefore,
this
review,
we
summarize
current
knowledge
regarding
functions
development.
Moreover,
provide
evidence
regulation
immunotherapy
Furthermore,
mention
multiple
compounds
that
target
improve
therapy
efficacy
We
hope
our
review
can
stimulate
researchers
clinicians
investigate
whether
how
targeting
acts
novel
strategy
for
therapy.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(5), С. 2939 - 2939
Опубликована: Март 3, 2024
Programmed
death
ligand
1
(PD-L1)
plays
a
pivotal
role
in
cancer
immune
evasion
and
is
critical
target
for
immunotherapy.
This
review
focuses
on
the
regulation
of
PD-L1
through
dynamic
processes
ubiquitination
deubiquitination,
which
are
crucial
its
stability
function.
Here,
we
explored
intricate
mechanisms
involving
various
E3
ubiquitin
ligases
deubiquitinating
enzymes
(DUBs)
that
modulate
expression
cells.
Specific
discussed
detail,
highlighting
their
roles
tagging
degradation.
Furthermore,
discuss
actions
DUBs
stabilize
by
removing
chains.
The
interplay
these
not
only
dictates
levels
but
also
influences
progression
patient
response
to
immunotherapies.
therapeutic
implications
targeting
regulatory
pathways
propose
novel
strategies
enhance
efficacy
PD-L1/PD-1-based
therapies.
Our
underscores
complexity
significant
impact
tumor
microenvironment
immunotherapy
outcomes.
Immunoglobulin
A
nephropathy
(IgAN),
one
type
of
glomerulonephritis,
displays
the
accumulation
glycosylated
IgA
in
mesangium.
Studies
have
demonstrated
that
both
genetics
and
epigenetics
play
a
pivotal
role
occurrence
progression
IgAN.
Post-translational
modification
(PTM)
has
been
revealed
to
critically
participate
IgAN
development
because
PTM
dysregulation
results
impaired
degradation
proteins
regulate
pathogenesis.
growing
number
studies
identify
PTMs,
including
sialylation,
o-glycosylation,
galactosylation,
phosphorylation,
ubiquitination
deubiquitination,
modulate
initiation
Hence,
this
review,
we
discuss
functions
mechanisms
PTMs
regulation
Moreover,
outline
numerous
compounds
govern
attenuate
progression.
Targeting
might
be
useful
strategy
ameliorate
Biomolecules,
Год журнала:
2024,
Номер
14(8), С. 908 - 908
Опубликована: Июль 25, 2024
Post-translational
modifications
(PTMs)
influence
protein
functionality
by
modulating
stability,
localization,
and
interactions
with
other
molecules,
thereby
controlling
various
cellular
processes.
Common
PTMs
include
phosphorylation,
acetylation,
ubiquitination,
glycosylation,
SUMOylation,
methylation,
sulfation,
nitrosylation.
Among
these
modifications,
O-GlcNAcylation
has
been
shown
to
play
a
critical
role
in
cancer
development
progression,
especially
hepatocellular
carcinoma
(HCC).
This
review
outlines
the
of
progression
HCC.
Moreover,
we
delve
into
underlying
mechanisms
HCC
highlight
compounds
that
target
O-GlcNAc
transferase
(OGT)
O-GlcNAcase
(OGA)
improve
treatment
outcomes.
Understanding
will
offer
insights
potential
therapeutic
strategies
targeting
OGT
OGA,
which
could
for
patients
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Авг. 23, 2024
Protein
post-translational
modifications
(PTMs)
represent
a
crucial
aspect
of
cellular
regulation,
occurring
after
protein
synthesis
from
mRNA.
These
modifications,
which
include
phosphorylation,
ubiquitination,
acetylation,
methylation,
glycosylation,
Sumoylation,
and
palmitoylation,
play
pivotal
roles
in
modulating
function.
PTMs
influence
localization,
stability,
interactions,
thereby
orchestrating
variety
processes
response
to
internal
external
stimuli.
Dysregulation
is
linked
spectrum
diseases,
such
as
cancer,
inflammatory
neurodegenerative
disorders.
UFMylation,
type
PTMs,
has
recently
gained
prominence
for
its
regulatory
role
numerous
processes,
including
stress,
key
signaling
pathways
influencing
functions.
This
review
highlights
the
function
UFMylation
development
progression
tumors,
underscoring
potential
therapeutic
target.
Moreover,
we
discuss
tumorigenesis
malignant
progression,
explore
impact
on
cancer
immunotherapy.
The
article
aims
provide
comprehensive
overview
biological
functions
propose
how
targeting
could
enhance
effectiveness
immunotherapy
strategies.
Frontiers in Oncology,
Год журнала:
2023,
Номер
13
Опубликована: Май 19, 2023
Skin
cutaneous
melanoma
(SKCM)
is
the
deadliest
type
of
malignancy.
Ubiquitination
a
process
protein
sorting
and
degradation
that
exhibits
multiple
functions
in
progression
various
tumors.
This
study
aimed
to
characterize
set
genes
for
ubiquitination
SKCM.The
expression
patterns
ubiquitin-associated
(URGs)
corresponding
clinical
information
SKCM
tissues
were
comprehensively
analyzed
based
on
The
Cancer
Genome
Atlas
(TCGA)
database.
We
performed
univariate
multivariate
Cox
proportional
regression
models
risk
scores
identify
four
critical
related
prognostic
(HCLS1,
CORO1A,
NCF1
CCRL2),
which
used
construct
signatures.
also
studied
effects
HCLS1,
CORO1A
CCRL2
tumor
metastasis-related
indicators
at
cellular
level
through
vitro
experiments.SKCM
patients
low-risk
group
showing
longer
survival
than
those
high-risk
group.
Characteristic
correlated
with
several
clinicopathological
variables
reflected
infiltration
immune
cells.
In
addition,
knockdown
CLS1,
affected
malignant
biological
behavior
EMT
signaling
pathway.This
provides
novel
prospective
strategy
improve
patients.